Mode
Text Size
Log in / Sign up

Open-angle glaucoma

Part of Glaucoma

7 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Open-angle glaucoma

172 trials tracked for Open-angle glaucoma: 79 in phase 3 or 4 and 17 with published results. The most-cited published study has 215 citations.

172Trials tracked
79Phase 3 & 4
0Recruiting
17With published results
Phase distribution
Phase 4 34 Phase 3 45 Phase 2 42 Phase 1 3 Other / NA 48
  1. Phase 4 Evaluation of the XEN Implant in Moderate Primary Open Angle Glaucoma (POAG) Participants Completed · 215 cited
  2. Phase 3 Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular Hypertension Completed · 127 cited
  3. Phase 3 Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension Completed · 108 cited
  4. Phase 3 Double-masked Study of PG324 Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension Completed · 88 cited
  5. Phase 3 Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension Completed · 88 cited
  6. Phase 3 Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension Completed · 71 cited
Show 44 more trials
  1. Phase 3 Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5% Completed · 61 cited
  2. Phase 3 Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension Completed · 29 cited
  3. Phase 3 Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular Hypertension Completed · 24 cited
  4. Phase 4 Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting Completed · 19 cited
  5. Phase 3 Clinical Study Comparing Two Models of a Travoprost Intraocular Implant Completed · 17 cited
  6. Phase 3 Efficacy and Safety Study of Netarsudil 0.02% Ophthalmic Solution Compared to Ripasudil Hydrochloride Hydrate 0.4% Ophthalmic Solution in Japanese Subjects With Primary Open Angle Glaucoma or Ocular Hypertension Completed · 15 cited
  7. Phase 3 A Phase 3b Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular Hypertension Completed · 14 cited
  8. Phase 3 Non-inferiority of PRO-122 Ophthalmic Solution vs KRYTANTEK Ofteno® in Glaucoma or Ocular Hypertension (CONFORTK) Completed · 12 cited
  9. Phase 3 Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular Hypertension Completed · 10 cited
  10. Phase 4 Efficacy of Travoprost/Timolol for Uncontrolled Intraocular Pressure Completed · 7 cited
  11. Phase 3 Evaluation of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma and Ocular Hypertension Completed · 6 cited
  12. Phase 4 Comparison of Intraocular Pressure (IOP)-Lowering Efficacy and Safety of AZORGA® Ophthalmic Suspension and COSOPT® Ophthalmic Solution Completed
  13. Phase 4 SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA) Completed
  14. Phase 4 Inhaled Corticosteroids: Effect on Intraocular Pressure in Patients With Controlled Glaucoma Completed
  15. Phase 4 Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01 % and Lumigan® 0.03% Unit Dose Completed
  16. Phase 4 Subconjunctival Versus Direct Mitomycin C in Trabeculectomy Completed
  17. Phase 4 Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study Completed
  18. Phase 4 Nailfold Capillary Blood Flow With Latanoprost Bunod Completed
  19. Phase 4 Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin Analogue Completed
  20. Phase 4 Patient Preference Comparison of AZARGA Versus COSOPT Completed
  21. Phase 4 Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) Reduction Completed
  22. Phase 4 Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z® Completed
  23. Phase 4 Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada Completed
  24. Phase 4 A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension Completed
  25. Phase 4 Efficacy of Changing to DUOTRAV® From Prior Therapy Completed
  26. Phase 4 24-hour IOP-lowering Effect of Brimonidine 0.1% Completed
  27. Phase 4 Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues Completed
  28. Phase 4 Adherence Assessment With Travalert Dosing Aid Completed
  29. Phase 4 A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH) Completed
  30. Phase 4 Dry Eye Study With Cosopt® Over 8 Weeks in Patients With Open-Angle Glaucoma or Ocular Hypertension (0507A-152)(COMPLETED) Completed
  31. Phase 4 A Study of 0.15% Brimonidine Tartrate in Patients With Primary Open Angle Glaucoma and Ocular Hypertension Completed
  32. Phase 4 A Study of 0.03% Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension Completed
  33. Phase 4 Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension Completed
  34. Phase 4 Evaluation of Intraocular Pressure Using Simbrinza™ in Patients With Open-Angle Glaucoma or Ocular Hypertension Completed
  35. Phase 4 Ologen Collagen Matrix Safety and Effective Comparison With Mitomycin-C(MMC) in Glaucoma Surgery Completed
  36. Phase 4 Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®) Completed
  37. Phase 4 Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension Completed
  38. Phase 4 Efficacy of Changing to TRAVATAN® From Prior Therapy Completed
  39. Phase 4 Safety and Efficacy of Bimatoprost/Timolol Fixed Combination Versus Latanoprost in Patients With Open-Angle Glaucoma Who Have Never Been Treated Completed
  40. Phase 4 Examination of Ocular Surface Effects With Administration of Travatan Z and XALATAN Completed
  41. Phase 4 A Single Dose Comfort Comparison of Travatan Z in One Eye Versus Xalatan in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension Completed
  42. Phase 4 Efficacy of Changing to TRAVATAN® From Prior Therapy Completed
  43. Phase 3 Efficacy and Safety of SPARC0912 and Reference0912 in Open Angle Glaucoma or Ocular Hypertension Completed
  44. Phase 3 Efficacy and Safety Assessment of T2347 Versus Xalacom® in Ocular Hypertensive or Glaucomatous Patients Completed

Showing the 50 most-cited and recently-updated of 172 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Glaucoma

Related studies from across the Glaucoma family.

Metformin use linked to modest glaucoma risk reduction in diabetic patients
Ophthalmology Meta-analysis
Metformin use linked to modest glaucoma risk reduction in diabetic patients Metformin use linked to lower glaucoma risk in people with diabetes
A large meta-analysis of diabetic patients found metformin use associated with a modest reduction in glaucoma incidence, though evidence cer…
A massive review of over 1.2 million patients suggests metformin might lower the chance of developing glaucoma compared to other diabetes dr…
Integrated care combining antiangiogenic bridging and ischemia-directed therapies supports long-term success in neovascular glaucoma management
Rheumatology Sys. Review
Integrated care combining antiangiogenic bridging and ischemia-directed therapies supports long-term success in neovascular glaucoma management Integrated care offers long-term success for neovascular glaucoma
This narrative review addresses neovascular glaucoma management in patients with retinal ischemia. The authors argue that long-term success …
A review suggests combining antiangiogenic bridging with ischemia management and surgery may help patients with neovascular glaucoma achieve…
Review of glaucoma management without reported intervention details or outcomes
Neurology Sys. Review
Review of glaucoma management without reported intervention details or outcomes Review finds no clear best treatment for glaucoma
This narrative review addresses glaucoma management but does not report specific interventions, comparators, or outcomes. The authors provid…
A review of glaucoma treatments found no single approach is clearly best. What this means for patients.
Motivational Interviewing Workshop Improves Communication Skills in Ophthalmology Residents
Ophthalmology RCT
Motivational Interviewing Workshop Improves Communication Skills in Ophthalmology Residents Motivational Interviewing Workshop Boosts Glaucoma Counseling Skills
This pilot RCT with 20 ophthalmology residents found that a 1-hour Motivational Interviewing workshop improved standardized patient encounte…
A simple one-hour class helps doctors talk to glaucoma patients in ways that actually change behavior and improve medication use.
Perioperative taVNS Reduces Pain and Insomnia After Glaucoma Surgery
Ophthalmology RCT
Perioperative taVNS Reduces Pain and Insomnia After Glaucoma Surgery Vagus nerve stimulation lowers pain after glaucoma surgery
This randomized trial of 94 patients undergoing glaucoma surgery found that perioperative transcutaneous auricular vagus nerve stimulation (…
A trial found that vagus nerve stimulation reduced pain and improved sleep for patients having glaucoma surgery under general anesthesia.
Retrospective review links higher TAPE score to better SLT outcomes in glaucoma
Ophthalmology
Retrospective review links higher TAPE score to better SLT outcomes in glaucoma New laser settings help lower eye pressure for years without extra drops
This retrospective review of 62 eyes undergoing lower-energy SLT found that higher TAPE scores were associated with lower IOP at 2 months an…
A new way to tune laser energy for glaucoma could keep pressure low for years while avoiding the need for daily eye drops.
Micropulse transscleral cyclophotocoagulation showed less pain and inflammation than continuous-wave in refractory glaucoma patients
Ophthalmology RCT
Micropulse transscleral cyclophotocoagulation showed less pain and inflammation than continuous-wave in refractory glaucoma patients New laser option for hard-to-treat glaucoma cuts pain and swelling
This prospective, randomized, single-blind study enrolled 52 patients with refractory glaucoma.
A gentler laser lowers eye pressure as well as older methods but causes less pain and swelling.
Review of portable visual field devices shows higher patient preference over table-mounted analyzers in rural glaucoma care
Ophthalmology
Review of portable visual field devices shows higher patient preference over table-mounted analyzers in rural glaucoma care Portable eye tests beat old machines for rural patients
This mixed methods review analyzed patient preferences among 271 respondents at three Alabama Federally Qualified Health Centers.
Rural patients with glaucoma preferred portable virtual reality eye tests over traditional machines, reporting higher satisfaction and comfo…
Polygenic risk score enrichment reduces sample size needs for coronary artery disease and inflammatory bowel disease trials
Genetics & Precision Medicine Cohort
Polygenic risk score enrichment reduces sample size needs for coronary artery disease and inflammatory bowel disease trials Smarter trial designs could cut study sizes by 60% for heart disease
This in silico observational cohort study used UK Biobank data to model trial designs enriched for polygenic risk.
Using genetic risk scores to pick high-risk volunteers could shrink trial sizes by 60% for heart disease and 78% for IBD, speeding up resear…
Preclinical study tests AI pipeline for glaucoma detection using Harvard dataset
Ophthalmology
Preclinical study tests AI pipeline for glaucoma detection using Harvard dataset New AI System Catches Glaucoma Cases That Other Tools Miss
This preclinical study evaluated a two-tier AI diagnostic pipeline for glaucoma using the Harvard Glaucoma Detection and Progression dataset…
This approach may help doctors spot glaucoma earlier by using AI to double-check its own uncertain findings.
GATT reduces IOP in normal-tension glaucoma patients over 24 months
Rheumatology Cohort
GATT reduces IOP in normal-tension glaucoma patients over 24 months GATT Surgery Lowers Eye Pressure for Years
This single-center retrospective case series evaluated gonioscopy-assisted transluminal trabeculotomy (GATT) in 9 patients with normal-tensi…
GATT surgery lowered eye pressure by an average of 4 mmHg for two years in patients with normal-tension glaucoma, offering a long-term alter…
Rare LOXL1 variants associated with exfoliation syndrome and secondary glaucoma risk in US cohorts
Genetics & Precision Medicine Cohort
Rare LOXL1 variants associated with exfoliation syndrome and secondary glaucoma risk in US cohorts Rare Gene Changes Might Protect Against Glaucoma
This cohort study analyzed exome array and sequence data from 1118 XFS/XFG cases and 3661 controls in the Mass Eye and Ear cohort, plus 284 …
Rare genetic changes in a specific eye gene may protect against glaucoma, offering hope for those with a family history of vision loss.